While PT-141 also causes nausea in many, its overall benefit-risk seems better than what apomorphine offered
von Scheidt M, Adkar SS, Krefting J, Hoermann G, Meggendorfer M, Bauer S, et al
FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
Intrathecal Stem Cell Therapy: Which Approach Is Used and Why
This allows us to create a plan that supports your body, rather than just fighting against it
How long do you stay on semaglutide for